≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

Endpoint Browser PheWeb

C3_MANTLE_CELL_LYMPHOMA_EXALLC

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C83.1
  • Cause of death: ICD-10 — C83.1
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9673
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

489

4. Check minimum number of events

None

489

5. Include endpoints

None

489

6. Filter based on genotype QC (FinnGen only)

489

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE_EXALLC

Extra metadata

First used in FinnGen datafreeze
DF12

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 489 140 349
Unadjusted period prevalence (%) 0.12 0.05 0.15
Median age at first event (years) 67.26 64.62 68.32

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
276
Matched controls
2758
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
323.0
275
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
1282.6
304.4
248
19
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
152.6
132
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
143.6
125
*
XW000
NOMESCO Finland
Bone marrow biopsy
79.9
143.5
159
46
L03AA02
ATC
filgrastim; parenteral
+∞
139.8
122
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
127.1
112
*
A03FA01
ATC
metoclopramide; systemic, rectal
37.9
124.9
169
110
WW500
NOMESCO Finland
Blood transfusion
97.2
124.8
133
26
JN4BD
NOMESCO Finland
Extensive body CT
43.1
118.3
151
75
M04AA01
ATC
allopurinol; systemic
18.9
100.1
192
297
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
96.6
87
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
96.6
87
*
9673/3-C42.1
ICD-O-3
Mantle cell lymphoma of bone marrow
+∞
93.1
84
*
A04AA01
ATC
ondansetron; systemic, rectal
89.9
80.3
87
14
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
29.1
80.3
112
63
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
74.4
68
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
70.9
65
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
807.3
66.9
63
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
206.9
64.0
64
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
12.3
59.0
120
162
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
58.4
54
*
9673/3-C77.9
ICD-O-3
Mantle cell lymphoma of lymph node, NOS
+∞
57.3
53
*
JN6AD
NOMESCO Finland
CT of torso and neck
178.4
56.2
57
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
56.2
52
*
JN4AD
NOMESCO Finland
Body CT examination
25.9
55.6
79
42
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
49.5
54.3
65
17
1XC02
NOMESCO Finland
NA
222.4
54.1
54
*
PJA10
NOMESCO Finland
Exploration of lymph nodes
588.3
51.1
49
*
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
296.1
49.8
49
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
49.5
49.3
59
15
9673/3-C77.8
ICD-O-3
Mantle cell lymphoma of lymph nodes of multiple regions
+∞
46.1
43
*
ZX120
NOMESCO Finland
Intravenous
11.5
45.4
92
115
H02AB06
ATC
prednisolone; systemic
6.8
45.1
212
905
H02AB02
ATC
dexamethasone; systemic
84.5
44.7
49
7
R50.9
ICD-10 Finland
Fever, unspecified
9.4
44.6
104
167
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
43.9
41
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
43.9
41
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
33.8
43.8
57
21
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
38.4
36
*
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
+∞
38.4
36
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
6.0
38.4
136
383
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
13.0
37.9
70
70
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
407.4
36.9
36
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
35.0
36.6
47
16
WF049
NOMESCO Finland
Radiotherapy of metastasis
381.3
34.7
34
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
34.1
32
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
132.9
33.5
35
*
Z51.5
ICD-10 Finland
Palliative care
24.3
33.1
47
23
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
33.0
31
*
J05AB11
ATC
valaciclovir; oral
7.1
30.4
82
154
ZX112
NOMESCO Finland
Subcutaneous
41.1
29.2
36
10
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
48.2
28.4
34
8
WW402
NOMESCO Finland
Leucoferesis
+∞
26.5
25
*
WW409
NOMESCO Finland
Other aferesis
+∞
26.5
25
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
25.4
24
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
25.4
24
*
WF002
NOMESCO Finland
Radical radiotherapy
142.8
25.0
26
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.8
24.6
174
853
N02AA05
ATC
oxycodone; systemic
5.7
24.0
76
171
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
37.1
23.9
30
9
WZC30
NOMESCO Finland
Teaching
6.3
23.5
68
136
XX3DW
NOMESCO Finland
Time consuming IT work
10.1
23.5
48
56
J01MA12
ATC
levofloxacin; systemic
4.4
22.9
100
316
ZX108
NOMESCO Finland
Inhalation
68.3
22.2
25
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
22.2
21
*
390
Kela drug reimbursment
Ibrutinib
+∞
22.2
21
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
22.2
21
*
TGC00
NOMESCO Finland
Bronchial lavation
13.2
22.0
39
34
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
124.8
21.9
23
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
11.3
21.5
41
42
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
65.3
21.2
24
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
14.7
20.8
35
27
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
20.7
72
178
212
Kela drug reimbursment
Gout
12.4
20.4
37
34
A02BC02
ATC
pantoprazole; systemic
3.7
20.1
215
1350
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
20.0
19
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
10.8
19.6
38
40
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
19.0
18
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
19.0
18
*
116
Kela drug reimbursment
Prostate cancer
+∞
19.0
18
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
203.0
18.8
19
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
7.7
17.6
42
63
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
45.2
17.5
21
5
UGC12
NOMESCO Finland
Flexible bronchoscopy
6.0
17.0
49
96
9673/3-C09.9
ICD-O-3
Mantle cell lymphoma of tonsil, NOS
+∞
16.8
16
*
D64.9
ICD-10 Finland
Anaemia, unspecified
4.3
16.4
66
186
1512
Kela drug reimbursment
Ibrutinib
+∞
15.8
15
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
+∞
15.8
15
*
1AA09
NOMESCO Finland
NA
+∞
15.8
15
*
L01XE27
ATC
[U] ibrutinib; oral
+∞
15.8
15
*
L01AA02
ATC
chlorambucil; oral
169.0
15.6
16
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
169.0
15.6
16
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
5.1
15.4
51
117
J18.9
ICD-10 Finland
Pneumonia, unspecified
3.0
15.1
119
563
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
14.7
14
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
+∞
14.7
14
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
56.3
14.0
16
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
+∞
13.6
13
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
13.6
13
*
EMA10
NOMESCO Finland
Biopsy of tonsil
146.8
13.6
14
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
146.8
13.6
14
*
B01AB10
ATC
tinzaparin; parenteral
7.4
13.4
32
48
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.3
13.4
79
300
EP1AE
NOMESCO Finland
Neck ultrasound examination
8.2
13.1
29
39
WX110
NOMESCO Finland
Local anesthesy
2.6
13.0
187
1221
H02AB07
ATC
prednisone; oral
3.6
13.0
65
219
D70.89
ICD-10 Finland
Neutropenic splenomegaly
21.3
12.6
18
9
R06AE07
ATC
cetirizine; oral
2.7
12.3
116
592
GD1AD
NOMESCO Finland
Thorax CT examination
7.7
12.2
28
40
JN4CD
NOMESCO Finland
Very extensive body CT
14.3
12.1
20
15
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
48.9
12.0
14
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
48.9
12.0
14
*
EMB10
NOMESCO Finland
Tonsillectomy
15.6
12.0
19
13
D69.5
ICD-10 Finland
Secondary thrombocytopenia
67.8
11.7
13
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
26.3
11.3
15
6
TDM10
NOMESCO Finland
Puncture of maxillary antrum
8.8
11.0
23
28
WX408
NOMESCO Finland
General anesthesy, balanced
2.8
10.6
80
351
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
114.1
10.5
11
*
L01EL01
ATC
ibrutinib; oral
+∞
10.5
10
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
10.5
10
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.4
10.3
38
97
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
5.0
10.3
33
73
R05
ICD-10 Finland
Cough
3.0
10.1
64
252
N02BE01
ATC
paracetamol; systemic, rectal
2.8
9.8
237
1885
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
18.3
9.5
14
8
ZXC50
NOMESCO Finland
Cryotherapy
13.0
9.5
16
13
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
9.4
9
*
C81.3
ICD-10 Finland
Lymphocyte depleted classical Hodgkin lymphoma
+∞
9.4
9
*
XX9CD
NOMESCO Finland
Very extensive complementary CT
+∞
9.4
9
*
9673/3-C80.9
ICD-O-3
Mantle cell lymphoma of unknown primary site
+∞
9.4
9
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
B02.9
ICD-10 Finland
Zoster without complication
4.4
9.3
34
86
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.4
9.0
19
24
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
7.0
8.8
21
32
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
8.6
129
795
NK6AN
NOMESCO Finland
Total body bone isotope imaging
92.7
8.5
9
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
92.7
8.5
9
*
130
Kela drug reimbursment
Malignant tumour
+∞
8.4
8
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
8.4
8
*
Y77
ICPC
Malignant neoplasm prostate
+∞
8.4
8
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
8.4
8
*
Z52.89
ICD-10 Finland
Donor of other organ or tissue
+∞
8.4
8
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
8.4
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.4
8
*
WW200
NOMESCO Finland
Immunization
6.0
8.3
22
39
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
4.9
8.2
26
57
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
34.4
8.1
10
*
J01DB01
ATC
cefalexin; oral
2.3
8.0
221
1746
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
8.0
92
499
J01MA14
ATC
moxifloxacin; systemic
3.3
8.0
41
140
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
8.4
7.7
16
20
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.9
7.7
31
87
A07AA02
ATC
nystatin; oral
4.2
7.6
28
72
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
25.8
7.6
10
*
B01AB05
ATC
enoxaparin; parenteral
2.2
7.6
91
499
L04.0
ICD-10 Finland
Acute lymphadenitis of face, head and neck
82.1
7.4
8
*
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
82.1
7.4
8
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
7.3
7
*
B72
ICPC
Hodgkin Lymphoma
+∞
7.3
7
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
127
Kela drug reimbursment
Transplant complication
16.3
7.3
11
7
J35.1
ICD-10 Finland
Hypertrophy of tonsils
30.9
7.2
9
*
L57.0
ICD-10 Finland
Actinic keratosis
3.6
7.0
31
94
UJF32
NOMESCO Finland
Coloscopy
2.2
7.0
82
443
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
41.0
6.8
8
*
A41.8
ICD-10 Finland
Other specified sepsis
9.0
6.6
13
15
J05AB01
ATC
aciclovir; systemic
2.4
6.6
58
274
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.1
6.5
89
511
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
71.4
6.4
7
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.8
6.4
15
23
A41.9
ICD-10 Finland
Sepsis, unspecified
4.8
6.4
20
44
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.9
6.3
37
138
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.6
6.3
27
80
ED1AA
NOMESCO Finland
Mandipular X-ray examination
18.5
6.3
9
5
N05CF01
ATC
zopiclone; oral
2.0
6.3
98
592
9673/3-C77.4
ICD-O-3
Mantle cell lymphoma of lymph nodes of inguinal region or leg
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
J02AC03
ATC
voriconazole; systemic
+∞
6.3
6
*
9673/3-C77.0
ICD-O-3
Mantle cell lymphoma of lymph nodes of head, face and neck
+∞
6.3
6
*
A79
ICPC
Malignancy NOS
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
WD315
NOMESCO Finland
Multiple therapy of methastized malignancy with biomodifiers
+∞
6.3
6
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
6.3
6
*
SPAT1153
SPAT
Removal of sutures
2.0
6.2
92
547
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.1
6.2
33
116
A05AA02
ATC
ursodeoxycholic acid; oral
12.9
6.1
10
8
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
4.8
6.1
19
42

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
343
403
26.16
310.21
9.8
2.6
u/l
242.8
243.2
0.02
333
378
(3045142) Bone marrow Pathology biopsy report
158
28
82.89
290.88
1.9
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
226
159
25.57
268.40
1.6
1.4
—
—
—
0
0
(4035726)
194
103
30.56
261.22
1.9
1.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
162
60
39.88
248.17
2.0
1.8
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
120
10
158.70
241.78
1.3
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
237
284
15.25
201.33
1.7
1.5
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
242
310
14.48
195.72
1.8
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
105
21
63.40
186.43
3.2
1.9
e9/l
1.3
0.8
1.78
70
13
(46235355) HIV 1 and 2 tests - Meaningful Use set
251
379
12.55
177.93
1.8
1.6
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
120
52
30.26
171.78
4.7
5.8
iu/ml
394.3
156.1
—
12
9
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
86
18
57.76
150.50
2.6
1.9
%
12.7
14.2
—
29
8
(3005719) IgG [Mass/volume] in Serum or Plasma
186
235
12.16
148.28
5.0
1.9
g/l
8.2
11.2
9.69
174
215
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
82
15
65.48
147.23
2.7
2.2
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
81
15
64.52
145.06
2.3
1.7
%
15.9
—
—
9
0
(3017181) Myelocytes/100 leukocytes in Blood
186
263
10.80
135.15
6.4
3.7
%
1.1
0.8
0.45
133
62
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
90
36
30.41
131.55
2.4
2.4
u/ml
1841.0
327.4
—
6
5
(3004809) Band form neutrophils/100 leukocytes in Blood
83
34
29.20
120.02
4.5
3.1
%
1.0
1.3
0.10
72
27
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
101
75
16.71
111.65
2.4
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
103
80
16.04
111.03
2.3
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
162
248
9.27
108.50
6.7
3.8
%
0.2
0.1
0.82
116
54
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
88
53
20.03
108.17
2.4
1.4
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
72
29
28.94
104.40
1.7
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
150
231
8.92
99.35
6.4
3.8
%
0.6
0.6
0.04
87
45
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
58
15
43.74
95.82
4.3
1.7
e6/l
392.4
1178.5
—
26
6
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
82
57
17.08
93.43
1.4
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
314
1070
6.41
91.45
6.8
2.5
umol/l
343.4
9985.2
5.63
305
919
(3012095) Magnesium [Moles/volume] in Serum or Plasma
219
541
6.52
91.28
7.5
2.6
mmol/l
0.8
0.8
1.36
213
496
(3022096) Basophils/100 leukocytes in Blood
375
1574
6.93
83.70
11.9
5.1
%
0.7
0.7
0.56
364
1458
(42870588) Differential panel, method unspecified - Blood
320
1180
5.95
82.85
10.6
5.1
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
378
1621
6.87
81.55
12.4
5.2
%
2.6
3.1
3.59
368
1499
(3019069) Monocytes/100 leukocytes in Blood
378
1631
6.80
80.65
12.8
5.5
%
10.0
8.9
7.00
369
1512
(3027945) Reticulocytes/100 erythrocytes in Blood
200
510
5.94
79.02
4.0
2.0
%
1.7
1.7
0.10
188
453
(3028026) IgM [Mass/volume] in Serum or Plasma
123
194
8.13
78.67
3.0
1.2
g/l
1.0
1.1
0.42
112
179
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
70
51
15.85
77.39
1.3
1.4
u/ml
104.8
109.7
—
12
7
(3002030) Lymphocytes/100 leukocytes in Blood
378
1669
6.57
77.29
12.7
5.3
%
30.8
26.4
6.13
369
1535
(3025159) Blasts/100 leukocytes in Blood
134
238
7.38
76.77
6.9
3.9
%
0.2
0.0
1.02
88
49
(3023520) Reticulocytes [#/volume] in Blood
168
380
6.21
75.30
4.0
2.1
e9/l
67.1
67.0
0.01
143
305
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
45
11
44.95
75.00
4.1
1.8
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
383
1749
6.49
74.04
11.9
5.0
e9/l
0.6
0.6
0.79
354
1500
(3018010) Neutrophils/100 leukocytes in Blood
371
1652
6.16
73.84
11.4
5.2
%
52.1
58.2
11.83
363
1534
(3006315) Basophils [#/volume] in Blood
383
1757
6.44
73.39
12.0
5.1
e9/l
0.0
0.0
4.33
354
1515
(3019198) Lymphocytes [#/volume] in Blood
386
1788
6.50
72.95
12.1
5.1
e9/l
1.9
1.8
0.14
363
1563
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
389
1844
6.43
70.58
20.0
3.8
umol/l
10.1
12.6
9.03
383
1725
(3013115) Eosinophils [#/volume] in Blood
385
1820
6.24
69.75
12.9
5.1
e9/l
0.2
0.2
9.50
363
1591
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
63
46
15.57
69.40
1.8
1.4
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
398
1951
6.59
68.54
34.8
5.9
e9/l
3.2
4.4
17.60
381
1697
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
66
54
13.97
68.09
1.8
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
69
64
12.39
65.79
1.8
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
52
29
19.95
65.49
2.8
1.4
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
50
27
20.51
63.86
2.9
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
47
22
23.53
63.75
6.2
2.3
%
25.4
45.3
—
17
10
(3024561) Albumin [Mass/volume] in Serum or Plasma
352
1625
5.16
63.33
9.9
3.7
g/l
34.5
35.3
1.81
336
1483
(3023368) Bacteria identified in Blood by Culture
282
1110
4.64
62.47
8.5
3.9
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
122
247
6.25
60.46
2.4
1.5
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
59
49
13.56
60.15
1.7
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
207
669
4.63
58.98
3.0
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
61
56
12.30
58.39
1.8
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
52
39
14.80
56.18
1.7
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
45
26
18.96
55.58
3.1
1.1
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
45
26
18.96
55.58
3.1
1.1
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
45
26
18.96
55.58
3.1
1.1
—
—
—
0
0
(44806118)
47
35
14.75
50.89
1.5
1.3
—
—
—
0
0
(44790048)
47
35
14.75
50.89
1.5
1.3
—
—
—
0
0
(44790047)
47
35
14.75
50.89
1.5
1.3
—
—
—
0
0
(44790049)
47
35
14.75
50.89
1.5
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
56
8
78.70
50.26
2.4
1.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
26
17.58
50.09
5.7
3.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
71
98
8.31
50.07
1.7
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
203
719
4.12
49.72
12.7
4.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
359
1888
4.39
49.04
12.5
5.6
mmol/l
1.2
1.2
0.73
302
1610
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
159
477
4.46
48.76
2.3
1.8
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
41
27
16.48
47.35
4.3
2.7
%
54.0
54.5
0.03
28
19
(3019832) Treponema pallidum Ab [Presence] in Serum
83
146
6.64
46.86
1.4
1.5
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
50
5
111.14
46.74
2.5
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
38
22
18.64
46.74
1.1
1.1
—
—
—
0
0
(3018418) pH of Serum or Plasma
249
1088
3.63
43.40
9.3
3.4
ph
7.4
7.4
0.58
66
171
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
152
477
4.17
43.33
2.3
1.7
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
38
26
15.76
42.95
2.8
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
56
71
8.78
42.18
1.3
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
73
129
6.48
40.84
2.5
3.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
51
60
9.37
40.70
3.2
1.7
pg
33.0
33.5
0.24
51
60
(3015377) Calcium [Moles/volume] in Serum or Plasma
259
1197
3.47
40.60
9.2
2.0
mmol/l
2.3
2.3
0.66
244
973
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
324
1729
3.59
40.00
11.4
5.1
mmol/l
1.2
1.2
0.46
313
1537
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
27
10
28.52
39.50
3.8
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
27
10
28.52
39.50
3.8
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
27
10
28.52
39.50
3.8
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
104
267
4.68
38.25
2.1
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
24
15.15
37.70
1.5
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
24
14.67
35.97
1.8
1.5
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
46
57
8.80
35.16
1.4
1.2
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
227
1037
3.22
35.03
2.8
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
192
797
3.32
34.79
23.3
4.4
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
27
14
20.35
34.68
3.9
1.1
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
27
14
20.35
34.68
3.9
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
27
14
20.35
34.68
3.9
1.1
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
27
14
20.35
34.68
3.9
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
50
70
7.84
34.55
1.6
1.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
42
48
9.48
34.15
2.4
2.8
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
45
57
8.59
33.77
1.4
1.2
u/ml
372.0
257.2
0.53
19
33
(3021589) Normoblasts [#/volume] in Blood
290
1557
3.12
33.22
20.4
8.5
e9/l
0.0
0.0
0.49
266
1269
(3037756) Immunofixation for Serum or Plasma
46
63
7.96
32.35
1.3
1.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
150
558
3.44
32.15
1.9
2.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
38
8
51.29
32.04
1.2
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
28
19
15.57
31.60
1.9
1.6
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
28
19
15.57
31.60
1.9
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
225
1087
2.98
30.49
6.1
2.3
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
153
609
3.20
28.98
2.4
1.2
g/l
1.9
2.9
6.16
123
353
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
288
1620
2.89
28.91
9.0
3.8
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
171
727
3.08
28.89
6.8
2.1
mmol/l
2.4
2.4
0.87
162
612
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
409
2821
3.75
28.01
25.4
5.3
u/l
82.0
76.7
1.76
400
2578
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
40
55
7.83
27.97
6.3
2.5
%
49.4
60.3
3.29
40
55
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
31
31
10.61
27.65
1.9
1.5
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
23
15
16.04
26.39
1.4
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
31
7
47.09
25.83
1.3
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
49
91
5.87
25.79
1.5
1.5
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
39
58
7.22
25.43
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
26
23
11.88
25.09
1.1
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
109
383
3.38
25.03
7.2
2.4
umol/l
7.8
9.0
0.22
99
333
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
35
47
7.94
24.92
1.3
1.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
25
21
12.49
24.91
1.1
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
180
843
2.80
24.85
5.5
2.1
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
21
14
15.63
23.77
1.4
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
31
38
8.64
23.75
1.2
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
28
6
49.32
23.57
4.4
1.0
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
110
5.06
22.74
2.0
1.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
108
399
3.19
22.68
4.5
3.3
mmol/l
2.0
2.2
0.20
89
323
(3000494) Fungus identified in Specimen by Culture
115
443
3.09
22.47
1.7
1.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
196
1001
2.60
22.31
3.7
2.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
168
799
2.68
22.08
3.0
2.2
e6/l
3.4
4.5
1.28
148
690
(21494434) Karyotype in Bone marrow
30
39
8.13
21.90
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
159
744
2.68
21.50
3.2
2.4
mosm/kgh2o
551.3
568.8
0.47
143
607
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
18
11
16.95
21.21
2.9
1.0
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
18
11
16.95
21.21
2.9
1.0
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
70
206
3.80
20.87
2.9
1.5
ug/l
23.9
4.2
0.47
56
163
(3013707) Erythrocyte sedimentation rate by Westergren method
387
2780
2.88
20.69
7.6
3.9
mm/h
15.6
12.3
3.15
367
2511
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
48
7.06
20.65
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
211
1151
2.47
20.49
4.1
3.0
e6/l
24.8
116.0
0.94
176
887
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
25
28
9.36
20.47
1.1
1.1
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
274
1686
2.42
20.24
10.0
11.0
inr
1.2
1.4
2.05
83
470
(3000093) Morphology [Interpretation] in Blood Narrative
28
37
7.97
20.15
1.0
1.1
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
197
1052
2.46
19.93
3.9
2.9
e6/l
0.3
0.5
1.30
162
784
(3002256) Pathology report gross observation
79
265
3.36
19.26
1.5
1.1
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
228
1316
2.37
19.19
4.8
3.4
e6/l
54.9
89.3
0.92
182
947
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
234
1371
2.36
18.96
4.4
2.9
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
338
2343
2.43
18.23
8.0
4.3
mmol/l
6.5
6.9
2.90
329
2191
(3000991) Gas panel - Venous blood
90
338
3.04
18.12
7.1
6.7
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
61
180
3.73
18.05
1.9
1.6
g/l
1.5
1.5
0.11
49
154
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
18
16
11.64
17.19
1.6
1.3
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
343
2434
2.37
16.89
6.0
4.2
e6/l
2.4
2572.1
—
7
46
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
243
3.25
16.67
1.7
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
165
889
2.29
15.64
1.7
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
19
21
9.37
15.64
1.5
1.5
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
14
11.78
15.38
1.1
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
44
117
4.03
15.03
1.9
1.3
mg/l
30.3
37.9
0.64
33
98
(3023419) Bacteria identified in Sputum by Culture
31
63
5.19
14.72
1.7
3.0
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
116
3.97
14.39
1.9
1.3
mg/l
52.8
52.8
0.00
34
96
(3025941) Bacteria identified in Stool by Culture
53
166
3.46
14.28
1.6
1.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
24
40
6.26
13.98
3.4
2.0
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
107
502
2.45
13.71
3.0
2.6
%
26.6
23.8
0.65
100
422
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
31
7.03
13.68
3.5
1.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
109
521
2.41
13.38
9.6
5.5
mmol/l
105.0
104.6
0.55
102
506
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
32
6.81
13.30
3.5
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
32
6.81
13.30
3.5
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
32
6.81
13.30
3.5
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
32
6.81
13.30
3.5
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
32
6.81
13.30
3.5
1.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
110
533
2.37
13.07
2.8
2.5
g/l
2.1
2.2
2.24
105
487
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
21
34
6.41
12.57
1.8
1.6
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
130
3.53
12.21
3.0
2.5
u/ml
0.4
0.4
0.79
28
76
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
42
126
3.55
12.07
3.0
1.3
g/l
0.4
0.4
0.03
37
112
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
16
20
8.24
11.94
1.8
1.5
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
16
20
8.24
11.94
1.8
1.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
168
998
2.04
11.84
2.1
2.1
mg/l
3.0
2.9
0.22
145
840
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
28
63
4.65
11.81
3.1
1.2
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
154
3.27
11.77
2.5
1.4
g/l
3.1
3.9
5.05
35
108
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
154
3.27
11.77
2.5
1.4
g/l
6.9
7.4
1.05
36
113
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
154
3.27
11.77
2.4
1.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
87
397
2.45
11.73
5.7
3.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
9
19.51
11.66
3.0
1.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
9
19.51
11.66
3.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
176
1071
2.01
11.54
4.1
3.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
32
83
4.06
11.29
2.1
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
15
19
8.11
11.06
2.1
6.1
—
34.0
—
0
5
(3036481) Cortisol [Moles/volume] in Serum or Plasma
71
305
2.55
10.85
1.9
1.7
nmol/l
387.9
353.7
0.70
66
270
(3009871) Measles virus Ab [Titer] in Serum
15
8
19.29
10.32
1.9
1.5
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
15
8
19.29
10.32
1.1
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
13
15
8.88
10.27
1.1
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
31
85
3.83
10.14
1.8
2.1
mg/l
9.5
12.4
1.18
31
79
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
22
47
4.85
9.86
1.2
1.2
miu/ml
85.6
115.9
—
5
13
(3009343) pH of Capillary blood
65
280
2.52
9.85
5.0
3.5
ph
7.5
7.4
3.22
13
31
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
16
8.32
9.78
7.0
1.3
u/l
264.5
191.9
0.87
13
16
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
42
144
3.10
9.76
2.6
1.4
g/l
3.0
3.1
0.24
36
109
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
12
14
8.76
9.38
5.0
1.4
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
28
77
3.80
9.13
2.4
2.6
%
14.5
16.4
2.28
16
42
(3001122) Ferritin [Mass/volume] in Serum or Plasma
212
1457
1.80
9.05
3.6
2.7
ug/l
413.9
154.8
7.20
196
1314
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
60
260
2.49
8.97
2.3
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
29
83
3.65
8.93
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
29
83
3.65
8.93
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
202
1374
1.80
8.89
3.3
3.1
ng/l
1558.4
1607.4
0.07
188
1175
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
64
287
2.42
8.88
5.1
3.5
kpa
4.9
5.2
2.21
64
264
(3012501) Base excess in Blood by calculation
28
79
3.70
8.80
2.8
4.9
mmol/l
2.1
2.9
0.70
15
52
(3035350) Ketones [Presence] in Urine by Test strip
247
1786
1.77
8.79
4.3
3.6
estimate
0.0
0.0
0.00
68
301
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
128
756
1.94
8.79
2.1
1.7
mg/l
2.7
1.4
0.86
112
577
(3022145) Colonoscopy Study observation
70
330
2.31
8.68
1.4
1.3
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
32
100
3.35
8.65
3.1
1.3
g/l
0.0
0.0
0.00
32
95
(40761536) Microorganisms panel - Urine sediment
63
287
2.37
8.44
5.0
3.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
11
9.26
8.11
1.1
1.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
326
2588
1.78
8.09
5.5
4.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
43
166
2.74
8.09
4.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
243
1777
1.73
8.09
5.5
4.8
estimate
0.0
0.0
0.00
72
303
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
11
5
22.45
8.04
1.1
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
11
14
8.01
8.02
2.5
2.0
nmol/l
2.7
4.2
0.64
11
14
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
16
31
5.30
7.98
1.3
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
31
100
3.24
7.97
1.5
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
31
100
3.24
7.97
1.5
1.2
—
—
—
0
0
(3010421) pH of Blood
31
101
3.21
7.85
3.0
4.6
ph
7.4
7.4
0.60
26
78
(42529406) Shigella sp [Presence] in Stool by Culture
31
101
3.21
7.85
1.5
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
86
458
2.07
7.85
2.0
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
245
1806
1.71
7.84
4.4
3.6
estimate
0.0
0.0
0.00
70
295
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
112
655
1.92
7.84
3.4
2.6
e6/l
0.9
1.0
0.17
67
381
(40768800) Prostate Pathology biopsy report
15
28
5.50
7.77
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
27
81
3.47
7.77
3.3
3.8
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
16
32
5.14
7.71
1.1
1.3
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
36
4.86
7.69
1.5
1.4
—
—
—
0
0
(40768443) Skin Pathology biopsy report
38
142
2.82
7.60
1.3
1.2
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
105
608
1.93
7.54
3.8
2.8
e6/l
1.0
1.6
0.70
60
335
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
175
1186
1.74
7.52
2.7
2.2
u/l
52.2
58.4
1.95
164
1090
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
37
4.72
7.46
1.5
1.4
e6/l
46026.4
58406.3
0.10
11
26
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
9
13.63
7.42
1.4
1.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
63
304
2.23
7.37
1.8
1.9
g/l
0.2
0.2
0.14
57
268
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
84
3.34
7.36
1.4
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
18
42
4.41
7.27
1.6
1.3
e6/l
2588.1
2372.6
0.07
13
31
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
7
16.03
7.26
1.5
2.0
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
11
7
16.03
7.26
1.1
1.0
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
26
81
3.33
7.07
1.3
1.3
ug/g
214.8
316.7
1.66
14
47
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
20
53
3.89
6.87
1.3
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
242
1820
1.65
6.87
2.9
2.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
21
60
3.61
6.51
1.1
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
10
7
14.55
6.42
3.3
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
46
206
2.36
6.40
5.7
3.6
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
161
1108
1.68
6.34
6.5
2.8
u/l
42.3
37.6
0.32
155
1049
(3026389) Candida sp identified in Specimen by Organism specific culture
16
39
4.21
6.13
1.3
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
37
153
2.53
6.11
2.7
1.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
10
8
12.73
6.10
1.2
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
10
16
6.36
5.97
1.7
2.4
u/ml
1415.2
807.4
—
10
16
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
190
1384
1.61
5.88
4.5
3.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
418
3714
1.86
5.60
48.3
13.6
mg/l
23.0
26.2
1.54
401
2887
(3004716) Salmonella sp identified in Stool by Organism specific culture
33
135
2.55
5.58
1.5
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
137
937
1.64
5.40
4.2
3.2
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
58
306
2.02
5.39
2.8
2.1
u/l
33.0
35.3
0.23
43
255
(3029937) Albumin [Presence] in Urine by Test strip
143
989
1.63
5.39
4.9
3.8
estimate
0.0
0.0
0.50
66
289
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
9
8
11.43
5.31
3.6
6.0
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
16
44
3.73
5.24
1.3
1.7
%
90.3
89.5
0.27
16
44
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
57
302
2.00
5.24
3.0
2.5
ml/min/173m2
56.0
61.8
0.51
19
119
(3010937) Rubella virus Ab [Presence] in Serum
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
0
+∞
5.22
1.2
0.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
35
4.09
5.20
1.0
1.1
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
68
384
1.90
5.20
1.3
1.3
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
20
65
3.17
5.12
1.1
1.9
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
23
82
2.89
5.05
1.2
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
45
223
2.12
4.94
5.3
2.3
%
1.2
1.2
0.20
45
223
(3021901) Oxygen saturation in Capillary blood
22
78
2.91
4.88
2.9
2.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
320
3649
0.64
4.86
5.8
6.6
mmol/mol
40.6
41.0
0.31
290
3350
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
216
1686
1.50
4.62
4.2
4.0
ng/l
31.1
48.2
1.80
180
1274
(3003327) Ova and parasites identified in Stool by Light microscopy
23
87
2.72
4.55
2.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
10
21
4.84
4.55
1.2
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
17
54
3.23
4.53
1.8
1.7
g/l
0.4
1.0
—
9
45
(3024139) IgG subclass 3 [Mass/volume] in Serum
12
30
4.08
4.46
2.1
1.2
g/l
0.3
0.3
—
6
23
(3028192) IgG subclass 2 [Mass/volume] in Serum
12
30
4.08
4.46
2.1
1.2
g/l
2.3
2.8
—
6
23
(3027135) IgG subclass 1 [Mass/volume] in Serum
12
30
4.08
4.46
2.2
1.2
g/l
5.4
6.6
—
5
23
(4062490)
12
30
4.08
4.46
2.1
1.2
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
122
846
1.59
4.45
3.5
4.0
ng/l
99.1
367.0
2.69
106
713
(3003396) Base excess in Arterial blood by calculation
80
498
1.73
4.44
8.4
5.8
mmol/l
1.9
1.3
0.51
60
381
(3019225) pH of Specimen
64
373
1.82
4.43
7.8
3.5
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
14
40
3.57
4.36
2.4
1.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
79
494
1.71
4.31
1.3
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
45
238
1.98
4.18
4.0
2.7
e9/l
5.3
4.0
0.34
36
167
(3019060) Gas panel - Arterial blood
54
308
1.85
4.01
7.1
4.1
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
51
286
1.87
3.99
3.5
2.8
g/l
116.5
130.9
3.30
51
281
(3028626) Oxygen [Partial pressure] in Capillary blood
23
94
2.52
3.94
2.8
2.8
kpa
7.9
7.8
0.03
23
85
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
22
88
2.57
3.93
1.8
2.4
%
88.4
84.0
0.58
22
83
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
186
1451
1.45
3.81
2.2
2.2
nmol/l
81.8
77.1
1.29
172
1252
(3020891) Body temperature
37
189
2.04
3.79
4.9
4.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
61
2.85
3.72
1.2
1.3
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
10
25
4.06
3.71
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
12
35
3.49
3.64
1.1
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
7
9
7.87
3.57
1.9
1.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
10
26
3.91
3.53
1.1
1.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
67
426
1.66
3.44
1.3
1.3
titre
1207.3
473.5
0.79
11
99
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
19
76
2.56
3.42
1.2
1.8
—
—
—
0
0
(3024471) HLA-A [Type]
7
10
7.08
3.37
1.0
1.0
—
—
—
0
0
(3044889) 12 lead EKG panel
320
2797
1.42
3.29
5.1
4.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
271
2303
1.40
3.28
3.9
3.1
u/l
66.2
51.1
1.23
248
2109
(3032057) Clostridioides difficile [Presence] in Stool
6
7
8.66
3.27
1.7
1.9
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
11
33
3.39
3.21
1.8
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
7
11
6.44
3.19
1.0
1.0
miu/ml
632.1
1794.3
—
7
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
68
2.55
3.07
1.1
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
9
21
4.35
3.00
1.2
1.0
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
15
57
2.68
2.99
3.9
2.4
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
12
40
3.05
2.99
3.3
3.7
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
17
69
2.52
2.99
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
22
101
2.23
2.97
1.5
1.5
iu/ml
0.1
0.3
—
9
24
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
8
17
4.77
2.93
1.0
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
8
17
4.77
2.93
1.0
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
28
143
2.02
2.91
3.4
3.8
mmol/l
3.8
3.9
0.74
23
134
(3035285) Chloride [Moles/volume] in Venous blood
15
58
2.64
2.90
3.9
2.3
mmol/l
105.7
105.3
0.14
15
58
(3041354) Potassium [Moles/volume] in Venous blood
15
58
2.64
2.90
3.9
2.3
mmol/l
4.2
4.1
0.26
15
58
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
6
9
6.73
2.87
2.3
1.1
nmol/l
156.2
69.7
—
6
9
(3048879) Bone marrow aspiration report
6
9
6.73
2.87
1.3
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
11
36
3.10
2.82
1.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
8
18
4.50
2.80
1.0
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
14
54
2.64
2.72
2.0
3.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
355
3852
0.71
2.71
4.5
5.5
mmol/l
2.7
2.6
1.13
311
3495
(3006184) Hemoglobin [Mass/volume] in Capillary blood
20
92
2.22
2.71
2.5
2.4
g/l
113.9
134.8
4.90
20
69
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
6
10
6.06
2.70
3.2
2.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
385
3528
1.43
2.66
38.9
12.6
ml/min/173m2
75.3
75.1
0.09
358
2830
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
341
3721
0.72
2.66
4.0
4.8
mmol/l
1.3
1.4
2.12
300
3374
(3021960) Folate [Moles/volume] in Serum or Plasma
136
1064
1.39
2.58
1.9
1.5
nmol/l
18.8
20.5
0.77
124
889
(40761539) Cells [Type] in Urine sediment by Light microscopy
5
7
7.20
2.55
1.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
36
211
1.76
2.51
12.5
8.4
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
114
872
1.40
2.46
1.7
1.8
nmol/l
1329.1
1153.1
1.05
88
665
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
34
2.98
2.42
1.3
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
347
3758
0.74
2.38
4.1
4.9
mmol/l
4.5
4.4
0.92
311
3428
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
5
8
6.30
2.37
1.2
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
8
6.30
2.37
1.0
1.0
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
10
35
2.90
2.31
1.0
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
7
18
3.93
2.26
3.9
2.4
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
18
86
2.13
2.25
1.2
1.3
e6/l
170.7
1330.6
0.49
18
75
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
18
86
2.13
2.25
1.2
1.2
e6/l
14.1
92.6
0.65
18
73
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
9
5.60
2.22
1.0
1.0
—
—
—
0
0
(3013512) EKG study
151
1228
1.33
2.20
4.7
4.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
19
3.72
2.16
1.9
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
9
30
3.04
2.15
3.8
2.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
332
3598
0.76
2.09
3.9
4.3
mmol/l
1.3
1.3
0.39
294
3238
(3048689) Calprotectin [Mass/mass] in Stool
49
328
1.55
2.09
1.9
2.1
ug/g
200.4
163.8
0.27
40
252
(1761482) Bacteria [#/volume] in Urine by Culture
21
112
1.91
1.99
3.7
4.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
7
21
3.37
1.97
1.1
1.2
mmol/l
5.0
2.1
—
7
21
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
8
27
2.99
1.94
1.8
1.3
ug/l
18.5
14.6
—
8
27
(3035880) pH of Pleural fluid
6
16
3.78
1.94
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
8
28
2.89
1.87
1.0
1.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
160
1.73
1.86
1.3
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
421
3986
1.40
1.84
43.8
16.8
mmol/l
139.4
139.7
1.81
416
3869
(3011397) Hemoglobin [Presence] in Urine by Test strip
110
876
1.33
1.83
4.2
3.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
12
4.20
1.82
1.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
9
35
2.60
1.81
1.3
1.5
—
314.0
—
0
5
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
421
3992
1.39
1.77
28.2
9.1
u/l
25.7
26.7
0.63
416
3807
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
82
1051
0.74
1.77
1.9
1.7
mmol/l
1.5
1.3
0.62
65
865
(3023103) Potassium [Moles/volume] in Serum or Plasma
421
3994
1.39
1.75
44.4
16.9
mmol/l
4.0
4.0
0.17
416
3876
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
13
3.87
1.72
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
14
3.60
1.62
18.2
2.8
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
5
14
3.60
1.62
18.2
2.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
26
406
0.62
1.59
1.3
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
13
245
0.52
1.57
1.7
1.9
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
8
33
2.45
1.54
1.3
1.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
19
108
1.79
1.53
3.9
3.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
15
3.36
1.52
1.0
1.3
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
21
2.88
1.51
2.2
2.1
—
—
—
0
0
(4015189)
6
21
2.88
1.51
1.7
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
122
1450
0.79
1.48
4.1
4.0
mg/mmol
11.2
8.1
0.25
73
950
(3012516) Albumin [Mass/volume] in Urine
115
1375
0.79
1.46
3.2
3.3
mg/l
534.5
220.1
0.29
70
906
(40768441) Liver Pathology biopsy report
5
16
3.15
1.44
1.2
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
41
290
1.45
1.40
4.0
4.2
ng/l
97.1
93.8
0.06
33
255
(1002224) Polysomnography panel
5
122
0.40
1.39
1.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
8
165
0.48
1.37
1.6
1.4
—
—
—
0
0
(40761535) Cells panel - Urine sediment
46
336
1.41
1.33
4.6
3.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
23
145
1.62
1.31
2.9
1.8
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
24
2.52
1.30
1.0
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
91
1.78
1.30
4.4
3.8
mg/l
34.2
26.5
0.48
11
61
(3009542) Hematocrit [Volume Fraction] of Blood
349
3272
1.23
1.29
37.5
15.0
%
36.6
39.8
6.83
213
2110
(3009508) Creatinine [Moles/volume] in Urine
120
1409
0.80
1.29
3.1
3.2
mmol/l
6.6
8.0
4.37
94
1164
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
38
523
0.70
1.28
4.1
5.0
%
32.2
31.8
0.10
31
344
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
35
2.31
1.27
3.3
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
5
116
0.43
1.26
1.8
1.9
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
238
1.46
1.24
1.2
1.2
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
84
681
1.28
1.24
1.2
1.2
u/ml
0.9
1.7
0.90
21
182
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
40
538
0.72
1.19
1.3
1.2
u/ml
1.5
12.1
3.17
17
191
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
200
1788
1.20
1.19
2.2
2.1
pmol/l
92.3
92.9
0.06
123
924
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
34
0.00
1.16
0.0
2.3
—
90.7
—
0
9
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
111
941
1.23
1.12
1.6
1.7
pmol/l
490.4
12680157.8
0.79
94
765
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
66
527
1.29
1.10
13.4
7.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
52
1.94
1.07
1.6
1.5
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
33
2.14
1.06
1.7
1.7
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
15
90
1.69
1.05
2.5
3.1
nmol/l
0.9
0.9
—
8
70
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
23
2.19
0.98
1.4
1.4
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
30
0.00
0.97
0.0
1.2
—
12.5
—
0
9
(3015171) Extractable nuclear Ab [Units/volume] in Serum
18
117
1.56
0.95
1.3
1.2
—
0.3
—
0
10
(3045424) Erythrocytes [Presence] in Urine
9
52
1.74
0.93
2.1
1.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
403
3881
1.22
0.91
34.0
13.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
8
43
1.87
0.87
4.8
1.8
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
6
31
1.95
0.84
1.2
1.0
—
314.0
—
0
5
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
19
130
1.48
0.82
1.0
1.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
19
130
1.48
0.82
4.7
2.1
g/l
2.6
0.2
—
9
39
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
8
47
1.71
0.81
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
47
581
0.79
0.81
1.3
1.2
iu/ml
11.4
41.4
5.64
11
175
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
56
460
1.25
0.78
1.7
2.5
ug/l
6.6
7.5
0.15
50
401
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
22
162
1.37
0.67
1.1
1.2
iu/ml
65.9
107.7
—
8
59
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
284
2694
1.13
0.65
3.9
3.4
pmol/l
15.1
15.0
0.12
259
2399
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
63
1.60
0.62
3.6
1.6
u/ml
17.3
30.6
—
10
63
(3000492) Spirometry study
38
308
1.25
0.62
1.5
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
365
3767
0.88
0.59
4.9
4.9
mmol/l
5.9
6.1
2.87
330
3382
(3022217) INR in Platelet poor plasma by Coagulation assay
72
626
1.18
0.59
29.8
27.4
inr
1.4
1.4
—
9
82
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
160
1726
0.89
0.56
5.0
3.8
%
20.3
24.0
3.01
86
828
(1761868) Lipid panel - Serum or Plasma
108
1193
0.88
0.55
2.9
3.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
6
38
1.59
0.54
1.0
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
423
4136
1.17
0.54
62.5
19.9
e9/l
192.7
236.8
31.72
417
3994
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
141
1297
1.12
0.53
2.2
2.1
u/l
157.0
301.5
1.41
136
1203
(3026361) Erythrocytes [#/volume] in Blood
423
4139
1.16
0.52
62.5
19.9
e12/l
4.1
4.5
40.86
415
3977
(3010813) Leukocytes [#/volume] in Blood
423
4140
1.16
0.51
62.4
20.0
e9/l
6.9
6.8
0.15
415
3981
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
15
111
1.36
0.47
1.5
1.6
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
5
85
0.58
0.45
4.6
2.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
5
31
1.62
0.43
1.4
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
15
195
0.76
0.42
1.3
1.4
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
199.7
—
0
15
(3029075) Extractable nuclear Ab panel - Serum
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.3
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
254
1.19
0.36
1.7
1.4
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
227
1.20
0.35
1.3
1.3
—
57.8
—
0
13
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
205
2141
0.93
0.34
5.1
3.9
ug/l
3.3
2.0
0.58
181
1901
(3024928) Oxygen saturation in Venous blood
13
100
1.31
0.34
3.3
2.6
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
6
87
0.69
0.33
1.0
1.6
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
83
1.33
0.32
1.4
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
72
0.69
0.26
1.2
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
332
3388
0.94
0.25
4.8
4.3
mu/l
2.1
2.4
0.24
303
3041
(3019150) Specific gravity of Urine by Refractometry
91
857
1.08
0.23
5.0
4.0
kg/l
1.0
1.0
1.11
14
138
(3005570) Glucose [Moles/volume] in Urine
5
42
1.19
0.21
1.4
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
6.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
11
0.00
0.21
0.0
7.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
11
0.00
0.21
0.0
6.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
27.2
—
0
11
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
10
0.00
0.21
0.0
1.7
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
14.4
—
0
10
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
11.3
—
894.8
—
0
13
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
13.0
—
1513.1
—
0
13
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
6
50
1.20
0.20
1.0
1.0
g/l
1.6
1.5
—
6
41
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
1.2
1.3
nmol/l
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
52
1.16
0.19
1.2
2.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
53
1.13
0.18
1.2
1.3
nmol/l
0.6
0.6
—
6
48
(3000330) Specific gravity of Urine by Test strip
23
207
1.12
0.15
3.9
3.4
—
—
—
0
0
(4034850)
13
147
0.88
0.11
20.7
12.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
115
0.87
0.10
1.2
1.3
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
45
1.11
0.10
1.2
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
16
145
1.11
0.09
2.8
1.8
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
13
116
1.12
0.09
1.5
2.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3022621) pH of Urine by Test strip
25
268
0.93
0.09
3.3
3.0
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
11
97
1.14
0.09
1.1
1.1
—
95.7
—
0
7
(3008898) HLA-B27 [Presence]
8
74
1.08
0.07
1.1
1.1
—
—
—
0
0
(4094501)
10
112
0.89
0.07
1.3
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
9
84
1.07
0.07
3.4
2.1
%
61.0
62.6
—
9
84
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
17
157
1.09
0.07
1.4
1.8
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
89
1.13
0.07
1.4
2.7
umol/l
32.1
33.6
—
10
74
(4010399)
28
292
0.96
0.04
1.5
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
13
140
0.93
0.04
1.5
1.8
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
118
1188
0.99
0.01
3.3
2.7
ug/l
0.7
0.7
0.07
83
817
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
22
225
0.98
0.00
3.1
2.4
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
13
127
1.02
0.00
2.4
1.9
nmol/l
50.6
42.3
0.64
13
120
(3013139) Helicobacter pylori Ag [Presence] in Stool
21
213
0.99
0.00
1.2
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
18.1
—
0
8
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.2
—
5.7
—
0
6
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.8
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
9
0.00
0.00
0.0
7.2
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
26.0
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
5
58
0.86
0.00
1.0
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
88
0.91
0.00
1.9
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
5
50
1.00
0.00
1.2
1.5
%
63.2
68.3
—
5
37

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MANTLE_CELL_LYMPHOMA_EXALLC – Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).